Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib

Pancreatic neuroendocrine carcinoma (panNEC) is a rare disease. The rearrangements of neurotrophic tropomyosin receptor kinase (NTRK) genes are oncogenic. And in the existed literatures, the prevalence of NTRK3 was only 0.1% in neuroendocrine tumors. NTRK inhibitor was approved for refractory and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wen-Chi, Chen, Ming-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871888/
https://www.ncbi.nlm.nih.gov/pubmed/36703785
http://dx.doi.org/10.3389/fonc.2022.1031396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871888/
https://www.ncbi.nlm.nih.gov/pubmed/36703785
http://dx.doi.org/10.3389/fonc.2022.1031396

Ejemplares similares